Osimertinib Is More Effective than Standard Therapy in EGFRT790M Tumors.
Sign Up to like & getrecommendations! Published in 2017 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-rw2017-040
Abstract: Osimertinib achieved better responses than platinum-pemetrexed in patients with EGFRT790M lung cancer. read more here.
Keywords: effective standard; standard therapy; egfrt790m tumors; therapy egfrt790m ... See more keywords